SCHEMBL9517980

SCHEMBL9517980

CCOC(=O)Oc1c(Cc2ccccc2)ccc2ccccc12

nearest known ligand 0.71

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9770378 0.89 GPR55 (0.44) —
SCHEMBL9514367 0.83 GAA (0.44) —
SCHEMBL9770383 0.83 GPR55 (0.44) —
SCHEMBL12315224 0.79 TYMS (0.47) KMT2ASMN1; SMN2
SCHEMBL9514689 0.77 CYP1A2 (0.45) —
SCHEMBL23271959 0.77 ALDH1A1 (0.45) MEN1KMT2ASMN1; SMN2
SCHEMBL17697658 0.76 PDE3B (0.44) SMN1; SMN2
SCHEMBL9749105 0.75 — —
SCHEMBL340868 0.75 GPR55 (0.46) —
SCHEMBL30004235 0.75 TSHR (0.48) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0511228-A4 ESTERS OF 2-ARYLMETHYL-1-NAPHTHOL DERIVATIVES AS 5-LIPOXYGENASE INHIBITORS — 1993-04-21 — — EP disclosed
EP-0511228-A1 ESTERS OF 2-ARYLMETHYL-1-NAPHTHOL DERIVATIVES AS 5-LIPOXYGENASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-11-04 — — EP disclosed
WO-1991010430-A1 ESTERS OF 2-ARYLMETHYL-1-NAPHTHOL DERIVATIVES AS 5-LIPOXYGENASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1991-07-25 — — WO disclosed
US-5006555-A Antiinflammatory, antithrombin, respiratory system disorder treatment E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-04-09 — — US disclosed
Send feedback